E2 Quasispecies specificity of hepatitis C virus association with allografts immediately after liver transplantation

Liver Transplantation

Volumn 10, Issue 2, 2004, Pages 208-216

  Hughes Jr , Michael G ^a,b   Rudy, Christine K ^a   Chong, Tae W ^a   Smith, Robert L ^a   Evans, Heather L ^a   Iezzoni, Julia C ^a   Sawyer, Robert G ^a   Pruett, Timothy L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Department of Pathology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ALLOGRAFT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; EXPLANT; GENETIC VARIABILITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; INOCULATION; INTRAOPERATIVE PERIOD; LIVER BIOPSY; LIVER DISEASE; LIVER PERFUSION; LIVER TRANSPLANTATION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SPECIES DIFFERENCE; STATISTICAL ANALYSIS; VIRUS ISOLATION;

AMINO ACID SEQUENCE; BLOOD CELLS; CONSENSUS SEQUENCE; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER; LIVER FAILURE; LIVER TRANSPLANTATION; MOLECULAR SEQUENCE DATA; POSTOPERATIVE PERIOD; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; VARIATION (GENETICS); VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS;

EID: 1242307251     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20060     Document Type: Article

References (35)

1. Wright TL, Pereira B. Liver transplantation for chronic viral hepatitis. Liver Transpl Surg 1995;1:30-42.
2. Ballardini G, De Raffele E, Groff P, Bioulac-Sage P, Grassi A, Ghetti S, et al. Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver. Liver Transpl 2002;8:10-20.
3. Vargas V, Krawczynski K, Castells L, Martinez N, Esteban J, Allende H, et al. Recurrent hepatitis C virus infection after liver transplantation: immunohistochemical assessment of the viral antigen. Liver Transpl Surg 1998;4:320-327.
4. Gretch DR, Bacchi CE, Corey L, dela Rosa C, Lesniewski RR, Kowdley K, et al. Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. Hepatology 1995;22:1-9.
5. Garcia-Retortillo M, Forns X, Feliu A, Moitinho E, Costa J, Navasa M, et al. Hepatitis C virus kinetics during and immediately after liver transplantation. Hepatology 2002;35:680-687.
6. Garcia JE, Puentes A, Suarez J, Lopez R, Vera R, Rodriguez LE, et al. Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to Hepg2 cells. J Hepatol 2002;36:254-262.
7. Rosa D, Campagnoli S, Moretto C, Guenzi E, Cousens L, Chin M, et al. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorometric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci U S A 1996;93:1759-1763.
8. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 1991; 175:220-228.
9. Kato N, Ootsuyama Y, Tanaka T, Nakagawa M, Nakazawa T, Muraiso K, et al. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res 1992;22:107-123.
10. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci U S A 1992;89:3468-3472.
11. Weiner AJ, Brauer MJ, Rosenblatt J, Richman KH, Tung J, Crawford K, et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 1991;180:842-848.
12. Penin F, Combet C, Germanidis G, Frainais PO, Deleage G, Pawlotsky JM. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. J Virol 2001;75: 5703-5710.
13. Rumin S, Berthillon P, Tanaka E, Kiyosawa K, Trabaud MA, Bizollon T, et al. Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro. J Gen Virol 1999;80:3007-3018.
14. Kato N, Ikeda M, Sugiyama K, Mizutani T, Tanaka T, Shimotohno K. Hepatitis C virus population dynamics in human lymphocytes and hepatocytes infected in vitro. J Gen Virol. 1998;79 (pt 8):1859-1869.
15. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 1994;68:1494-1500.
16. Zibert A, Schreier E, Roggendorf M. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 1995;208:653-661.
17. Zhou YH, Shimizu YK, Esumi M. Monoclonal antibodies to the hypervariable region 1 of hepatitis C virus capture virus and inhibit virus adsorption to susceptible cells in vitro. Virology 2000;269:276-283.
18. Farci P, Shimoda A, Wong D, Cabezon T, De Gioannis D, Strazzera A, et al. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci U S A 1996;93:15394-15399.
19. Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A 1994;91:7792-7796.
20. Yagnik AT, Lahm A, Meola A, Roccasecca RM, Ercole BB, Nicosia A, et al. A model for the hepatitis C virus envelope glycoprotein E2. Proteins 2000;40:355-366.
21. Flint M, Maidens C, Loomis-Price LD, Shotton C, Dubuisson J, Monk P, et al. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J Virol 1999;73:6235-6244.
22. Lin HJ, Seeff LB, Barbosa L, Hollinger FB. Occurrence of identical hypervariable region 1 sequences of hepatitis C virus in transfusion recipients and their respective blood donors: divergence over time. Hepatology 2001;34:424-429.
23. Higashi Y, Kakumu S, Yoshioka K, Wakita T, Mizokami M, Ohba K, et al. Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology 1993;197:659-668.
24. Ray SC, Mao Q, Lanford RE, Bassett S, Laeyendecker O, Wang YM, et al. Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees. J Virol 2000;74:3058-3066.
25. Martell M, Esteban JI, Quer J, Vargas V, Esteban R, Guardia J, Gomez J. Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation. J Virol 1994;68:3425-3436.
26. Loriot MA, Bronowicki JP, Lagorce D, Lakehal F, Persico T, Barba G, et al. Permissiveness of human biliary epithelial cells to infection by hepatitis C virus. Hepatology 1999;29:1587-1595.
27. Cabot B, Martell M, Esteban JI, Sauleda S, Otero T, Esteban R, et al. Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver. J Virol 2000;74:805-811.
28. Pelletier SJ, Raymond DP, Crabtree TD, Berg CL, Iezzoni JC, Hahn YS, et al. Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate. Hepatology 2000;32:418-426.
29. Humphries SE, Gudnason V, Whittall R, Day IN. Single-strand conformation polymorphism analysis with high throughput modifications, and its use in mutation detection in familial hypercholesterolemia. international federation of clinical chemistry scientific division: committee on molecular biology techniques. Clin Chem 1997;43:427-435.
30. Henikoff S, Henikoff J. Amino Acid substitution matrices from protein blocks. Proc Natl Acad Sci U S A 1992;89:10915-10919.
31. Hamming R. Coding and Information Theory. Englewood Cliffs, NJ: Prentice-Hall; 1986.
32. Sakamoto N, Enomoto N, Kurosaki M, et al. Comparison of the hypervariable region of hepatitis C virus genomes in plasma and liver. J Med Virol 1995;46:7-11.
33. Fan X, Di Bisceglie AM. Genetic complexity and serum reactivity of HVR1 quasispecies of hepatitis C virus in patients with cirrhosis. Am J Gastroenterol 2002;97:1489-1495.
34. Wolinsky SM, Korber BT, Neumann AU, Daniels M, Kunstman KJ, Whetsell AJ, et al. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 1996;272:537-542.
35. Pawlotsky JM, Germanidis G, Frainais PO, Bouvier M, Soulier A, Pellerin M, Dhuumeaux D. Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy. J Virol 1999;73:6490-6499.